SUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational clinical trial. This Phase I China registrational clinical trial for XS228 Cell Injection – the world's first "off-the-shelf", allogeneic, iPSC-derived, spinal neural progenitor cell therapy targeting major neurological...
Hands-on learning helps build confidence, yet only half of students have access to these experiences in science lessons, according to a new LEGO® Education...
BEIJING, Jan. 14, 2025 /PRNewswire/ -- On January 13th and 14th, 2025, the 18th Asian Financial Forum 2025 (AFF), co-organised by the Hong Kong Special Administrative Region (HKSAR) Government and the Hong Kong Trade Development Council...
Free registration with generous rewards!
High winning rate, and professional project guidance throughout the entire process!
All participating contestants will receive free training opportunities, and winning...
PISTOIA, Italy, Jan. 14, 2025 /PRNewswire/ -- Starting in January 2025, Elitewheels, a leading Chinese manufacturer of carbon fiber bicycle wheels, is excited to announce...
PORT VILA, Vanuatu, Jan. 14, 2025 /PRNewswire/ -- Vantage Markets has been honored with "Best Range of Markets" award for 2025 by Compare Forex Brokers,...